Except for the well-known anti-inflammatory oncogene, there has been no report indicating the antioxidant characteristics of CXCL5 in prostate cancer; however, a recent study illustrated CXCL5 as having antioxidation characteristics in mouse adipocytes [11]. Here, CXCL5 is linked to prostate carcinoma.